Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.83 |
| ▸ | CES2 | O00748 | 5/20 | 0.83 |
| ▸ | HPGD | P15428 | 4/20 | 0.83 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.83 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.83 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.83 |
| ▸ | CES1 | P23141 | 4/20 | 0.83 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.83 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.83 |
| ▸ | MAPT | P10636 | 3/20 | 0.83 |
| ▸ | RECQL | P46063 | 3/20 | 0.83 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.83 |
| ▸ | BLM | P54132 | 3/20 | 0.83 |
| ▸ | IDO1 | P14902 | 3/20 | 0.83 |
| ▸ | POLB | P06746 | 2/20 | 0.83 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.83 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cryptotanshinone SCHEMBL29387944 | 0.91 | MEN1 (1.00) | MEN1ALDH1A1KMT2ACES2HPGD | |
| Cryptotanshinone SCHEMBL5940386 | 0.91 | MEN1 (1.00) | MEN1ALDH1A1KMT2ACES2HPGD | |
| Cryptotanshinone SCHEMBL4126834 | 0.91 | MEN1 (1.00) | MEN1ALDH1A1KMT2ACES2HPGD | |
| Cryptotanshinone SCHEMBL28181278 | 0.82 | MEN1 (0.83) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL16421131 | 0.82 | MEN1 (0.57) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL25752309 | 0.77 | MEN1 (0.75) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL13883845 | 0.76 | MEN1 (0.74) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL3332927 | 0.74 | PTPN1 (0.69) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL22875593 | 0.74 | PTPN1 (0.69) | MEN1ALDH1A1KMT2ACES2HPGD | |
| SCHEMBL13855041 | 0.73 | PTPN1 (0.64) | MEN1ALDH1A1KMT2ACES2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116718718-A | Qualitative detection method for blood component of musk heart-activating dripping pills | 内蒙古康恩贝药业有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-113005130-B | Tanshinone IIA synthase gene and application thereof | 上海辰山植物园 | 2022-07-08 | — | — | CN | claimed |
| CN-119925445-A | Use of natural plant active ingredients for preventing and/or treating ovarian dysfunction diseases | 中国科学院生物物理研究所 | 2025-05-06 | — | — | CN | disclosed |
| CN-119380826-B | Chinese patent medicine network pharmacology analysis method and model construction method based on multiscale information entropy | 首都医科大学附属北京朝阳医院 | 2025-04-08 | — | — | CN | disclosed |
| CN-119700855-A | Method for extracting total tanshinone from red sage root dregs and application thereof | 国药集团宜宾制药有限责任公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119431133-A | New cryptotanshinone Process for the preparation of ketones | 中医药广东省实验室 | 2025-02-14 | — | — | CN | disclosed |
| CN-119380826-A | Chinese patent medicine network pharmacology analysis method and model construction method based on multiscale information entropy | 首都医科大学附属北京朝阳医院 | 2025-01-28 | — | — | CN | disclosed |
| CN-119015340-A | Method for separating and purifying tanshinone in red sage root | 江西绿天食品有限公司 | 2024-11-26 | — | — | CN | disclosed |
| EP-3040077-B1 | TRADITIONAL CHINESE MEDICINE COMPOSITION | TASLY PHARMACEUTICAL GROUP CO (CN) | 2024-10-02 | — | — | EP | disclosed |
| EP-3777866-B1 | PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | TASLY PHARMACEUTICAL GROUP CO (CN) | 2024-08-21 | — | — | EP | disclosed |
| CN-118217325-A | Danzhiqing tablet dry extract and preparation method thereof | 华润三九医药股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-113791154-B | Method for identifying chemical components in Xuebijing injection | 天津中医药大学 | 2023-06-23 | — | — | CN | disclosed |
| US-20230147718-A1 | COMPOSITION FOR CANCER PREVENTION OR TREATMENT, CONTAINING, AS ACTIVE INGREDIENT, SALVIANOLIC ACID B OR TANSHINONE I | GJMEDI (KR) | 2023-05-11 | — | — | US | disclosed |
| EP-4154878-A1 | APPLICATION OF ACTIVE INGREDIENT OF ROOT OF LIGULILOBE SAGE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN PREPARING ANTIVIRAL DRUG | Southern Medical University (CN) | 2023-03-29 | — | — | EP | disclosed |
| CN-115487280-A | Traditional Chinese medicine composition for relieving alcoholism, protecting liver and promoting liver regeneration, preparation and preparation method thereof | 浙江中医药大学 | 2022-12-20 | — | — | CN | disclosed |
| US-11491173-B2 | Pharmaceutical composition and application thereof | TASLY PHARMACEUTICAL GROUP CO., LTD. (CN) | 2022-11-08 | — | — | US | disclosed |
| CN-113318205-B | Traditional Chinese medicine composition for treating pleural effusion and pericardial effusion | 吉林省中医药科学院（吉林省中医药科学院第一临床医院） | 2022-10-28 | — | — | CN | disclosed |
| CN-113005130-B | Tanshinone IIA synthase gene and application thereof | 上海辰山植物园 | 2022-07-08 | — | — | CN | disclosed |
| CN-114176171-A | Feed additive for increasing yield of poultry and preparation method thereof | 河南省奥邦生物科技有限公司 | 2022-03-15 | — | — | CN | disclosed |
| CN-114085264-A | A method for preparing tanshinone IIA extracted from Saviae Miltiorrhizae radix | 河南省康华药业股份有限公司 | 2022-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11491173-B2 | Pharmaceutical composition and application thereof | TNNT2, TNNI3, FABP3 | MEN1 4715/4885ALDH1A1 1692/4885KMT2A 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.